Results 251 to 260 of about 3,189,219 (271)

A Study to Assess and Improve Adherence to Iron Chelation Therapy in Transfusion-Dependent Thalassemia Patients

Hemoglobin, 2021
Piti Techavichit, Darintr Sosothikul, Supanun Lauhasurayotin   +2 more
exaly  

Objectives of iron chelation therapy in myelodysplastic syndromes: more than meets the eye?

Blood, 2009
Vinod Pullarkat
exaly  

Effect of transfusional iron intake on response to chelation therapy in β-thalassemia major

Blood, 2008
Alan R Cohen, Ekkehard Glimm
exaly  

Iron chelation therapy in myelodysplastic syndromes: where do we stand?

Expert Review of Hematology, 2013
Amer M Zeidan, Mhairi Mitchell
exaly  

Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM

Leukemia Research, 2010
Laurent Pascal, Pierre Fenaux, Odile Beyne-Rauzy   +2 more
exaly  

Costs, quality of life, treatment satisfaction and compliance in patients with β-thalassemia major undergoing iron chelation therapy: the ITHACA study

Current Medical Research and Opinion, 2008
Diana Rofail, Maria Domenica Cappellini, Marieke Krol   +2 more
exaly  

Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload

Leukemia Research, 2007
Norbert Gattermann
exaly  

Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload

International Journal of Hematology, 2008
Norbert Gattermann
exaly  

Iron chelation, angiogenesis and tumor therapy

International Journal of Cancer, 2003
Linden, T, Wenger, R H
openaire   +2 more sources

Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy

Leukemia Research, 2007
Heather A Leitch
exaly